Tonix Pharmaceuticals Holding Corp. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TNXP Nasdaq 2836 www.tonixpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Highlights TONMYA Sales Surge, Lyme and Depression Pipeline - Aug 18th, 2026 1:01 am
Tonix Pharmaceuticals (TNXP) Q2 2026 Earnings Call Transcript - Aug 17th, 2026 8:44 am
Tonix Pharmaceuticals Holding Corp (TNXP) (Q2 2026) Earnings Call Highlights: TONMYA Surges ... - Aug 10th, 2026 3:01 pm
Tonix Pharmaceuticals Q2 Earnings Call Highlights - Aug 10th, 2026 10:04 am
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences - Aug 5th, 2026 5:00 am
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S. - Aug 3rd, 2026 5:00 am
Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026 - Jul 27th, 2026 5:00 am
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models - Jul 15th, 2026 7:05 am
Tonix Expands TONMYA Medicare Coverage with New Payer Agreement (TNXP) - Jul 13th, 2026 6:21 am
Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA® - Jul 13th, 2026 5:00 am
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD) - Jun 29th, 2026 5:25 am
Qualcomm upgrade, Intel initiation among today's top calls on Wall Street - Jun 25th, 2026 7:34 am
We're Keeping An Eye On Tonix Pharmaceuticals Holding's (NASDAQ:TNXP) Cash Burn Rate - Jun 13th, 2026 6:43 am
Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 - Jun 11th, 2026 5:00 am
Why Is TNXP Stock Rising Today? - Jun 8th, 2026 7:46 am
Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives - Jun 8th, 2026 5:00 am
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting - May 28th, 2026 2:30 pm
Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology - May 27th, 2026 5:00 am
Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting - May 26th, 2026 5:00 am